CLINICAL_TRIALS
research
· 2026-02-09
Clinical Trial Update: CorWave LVAS FIH Study [NA]
Summary
CorWave's left ventricular assist system (LVAS) first-in-human study is currently recruiting for advanced heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CorWave | Conditions: Advanced Heart Failure | NA | Status: RECRUITING